Exact Sciences Corporation (EXAS)

Business: Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally.

IPO Date: 01-Feb-2001

Chairman of The Board & CEO: Mr. Kevin T. Conroy

Exec. VP, CFO & COO: Mr. Jeffrey T. Elliott CFA

Listing: NASDAQ: EXAS

Country: United States

Headquarters: Madison, WI

Website: https://www.exactsciences.com

Market cap: $7,236.62 Mln

Revenue (TTM): $1,851.58 Mln

Earnings (TTM): $-745.40 Mln

Cash: $816.98 Mln

Total Debt: $2,382.02 Mln

Insider's Holding: 0.89%

Liquidity: Low

52 Week range: $35.34 - 125.00

Shares outstanding: 175,944,992

10 Years Aggregate:

• CFO: $-650.26 Mln
• EBITDA: $-2,138.59 Mln
• Net Profit: $-2,341.74 Mln